Lower statin doses effective in familial hypercholesterolaemia Clinical study 02 February 2013 Pages: 1 - 1
Move to decrease racial disparities in clinical trial enrolment Comment 02 February 2013 Pages: 3 - 3
Rad results for radezolid in skin and soft tissue infections Clinical study 02 February 2013 Pages: 6 - 6
CONSORT statement extensions for pragmatic trials announced Guideline 02 February 2013 Pages: 10 - 10
Single-dose corifollitropin-α rivals daily follitropin-β Clinical study 02 February 2013 Pages: 11 - 11
Tailored clopidogrel dosing leads to benefits after angioplasty Media release 02 February 2013 Pages: 12 - 12
STARTMRK sets pace for raltegravir's first-line finish for HIV Meeting report 02 February 2013 Pages: 13 - 14
Drug-eluting stents beat bare metal stents in diabetic patients News item 02 February 2013 Pages: 14 - 14
Statins enter new space with CV risk reduction in healthy patients Meeting report 02 February 2013 Pages: 15 - 16
SEARCH finds folic acid safe, but not cardioprotective Meeting report 02 February 2013 Pages: 17 - 17
Darunavir hunts down lopinavir: the 96 week ARTEMIS results Clinical study 02 February 2013 Pages: 18 - 18
Chemotherapy related to death in very sick cancer patients? Clinical study 02 February 2013 Pages: 19 - 19
Rosiglitazone not the right APPROACH for atherosclerosis Clinical study 02 February 2013 Pages: 19 - 19
An international covert operation targeting illegal Internet sale of medicines News item 02 February 2013 Pages: 20 - 20
Researchers give heads up over ifosfamide encephalopathy Incidence study 02 February 2013 Pages: 21 - 21
Bisphosphonates and increased AF rates: FDA says no clear link Media release 02 February 2013 Pages: 22 - 22
Latest European approval for new antihypertensive therapy announced. Media release 02 February 2013 Pages: 22 - 22
Methylnaltrexone bromide approved for OIC in Australia. Media release 02 February 2013 Pages: 22 - 22
New treatment for postmenopausal dyspareunia approved in US. Media release 02 February 2013 Pages: 22 - 22